Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Thomas L. Rodgers net worth and biography

Thomas Rodgers Biography and Net Worth

EVP of McKesson

Tom Rodgers, Executive Vice President & Chief Strategy and Business Development Officer of McKesson Corporation, is an accomplished business leader with decades of experience in senior executive roles. Tom oversees McKesson’s overall strategic plan and initiatives as well as key acquisitions and venture investments. Tom previously led the launch and successful scaling of McKesson’s Venture fund and served as senior vice president and managing director of McKesson Ventures for its first six years.

Tom has more than twenty-five years of experience working in both emerging companies and large healthcare environments. Previously Tom served as Director, Strategic Investments at Cambia Health and was a partner at Advanced Technology Ventures, where he led the fund’s investments in healthcare technology.

Tom previously worked for McKesson from 1999 to 2004 as Vice President, Corporate Strategy and Business Development and prior to that he worked at Genentech, IBM, and Fitlinxx. His investments and board experience spans numerous innovative companies across the healthcare landscape including Accolade, Zeltiq, Aperio, Hims, Aetion, Helixis, Grail, AmWell, Kyruus and PharmaPacks.

Tom holds an MBA from the Wharton School and a bachelor’s degree from the University of Pennsylvania.

What is Thomas L. Rodgers' net worth?: The estimated net worth of Thomas L. Rodgers is at least $1.34 million as of June 6th, 2023. Mr. Rodgers owns 2,544 shares of McKesson stock worth more than $1,335,168 as of April 20th. This net worth evaluation does not reflect any other investments that Mr. Rodgers may own. Learn More about Thomas L. Rodgers' net worth.
How do I contact Thomas L. Rodgers?: The corporate mailing address for Mr. Rodgers and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on Thomas L. Rodgers' contact information.
Has Thomas L. Rodgers been buying or selling shares of McKesson?: Thomas L. Rodgers has not been actively trading shares of McKesson during the past quarter. Most recently, Thomas L. Rodgers sold 645 shares of the business's stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $395.70, for a transaction totalling $255,226.50. Following the completion of the sale, the executive vice president now directly owns 2,544 shares of the company's stock, valued at $1,006,660.80. Learn More on Thomas L. Rodgers' trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), Marie Knowles (Director), Erin Lampert (SVP), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 20 times. They sold a total of 130,252 shares worth more than $56,328,345.62. The most recent insider tranaction occured on March, 15th when CEO Brian S Tyler sold 3,473 shares worth more than $1,821,762.15. Insiders at McKesson own 0.2% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 3/15/2024.

Thomas L. Rodgers Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/6/2023	Sell	645	$395.70	$255,226.50	2,544
9/8/2022	Sell	1,300	$367.21	$477,373.00	2,544
6/6/2022	Sell	160	$316.42	$50,627.20	3,844
5/26/2022	Sell	527	$330.27	$174,052.29	3,362
5/24/2022	Sell	209	$326.90	$68,322.10	3,353
6/8/2021	Sell	198	$192.85	$38,184.30	1,161
6/1/2021	Sell	145	$189.56	$27,486.20	12,910

Thomas L. Rodgers Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $524.83

$517.01

$525.83

50 Day Range

MA: $524.91

$494.48

$540.10

2 Week Range

Now: $524.83

$352.34

$543.00

Volume

645,368 shs

Average Volume

454,051 shs

Market Capitalization

$68.97 billion

P/E Ratio

23.78

Dividend Yield

0.48%

Beta

0.45

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad